NCT02797015 - Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 23, 2016

Primary Completion Date

October 20, 2017

Study Completion Date

October 20, 2017

Conditions

Multiple Sclerosis

Interventions

DRUG

RPC1063

Oral capsule daily

Trial Locations (6)

Raleigh Neurology Associates PA, Raleigh

Hope Neurology MS Center, Knoxville

Neurology and Neuroscience Associates Inc., Akron

Central Texas Neurology Consultants PA, Round Rock

Breastlink Medical Group, Inc., Long Beach

Multiple Sclerosis Center at UCSF, San Francisco